US 8,343,478 B2 · Parapoxviruses in combination with other antiviral agents for the treatment of viral diseases

Abstract

The present invention relates to the use of Parapoxviruses in combination with other agents for the treatment of viral diseases, and in particular HIV infections and AIDS. The invention also relates to methods for producing medicaments based on combinations of Parapoxviruses and other antiviral agents, and to such medicaments. In particular, the invention relates to the use of Parapoxviruses in combination with agents of the kind used for antiretroviral therapy and highly active antiretroviral therapy (HAART).

Claims14

Dependent claims

A method of producing a medicament for treating a viral disease, comprising the following steps:

(1) Providing Parapoxvirus ovis strain NZ2 in a therapeutically effective amount,
(2) Providing at least one additional antiviral agent in a therapeutically effective amount,
(3) Combining said amount of Parapoxvirus and said amount of additional antiviral agent to obtain a combination, and
(4) Formulating said combination into a pharmaceutically acceptable excipient,
wherein said viral disease is an HIV infection and/or AIDS, and wherein said at least one additional antiviral agent is selected from the group consisting of:
an agent for Highly Active Antiretroviral Therapy (HAART), zidovudine (AZT), lamivudine (3TC), and Tenofovir (PMPA).

3 more elements

Dependencies are inferred from the claim text.

Facts

Application

11/652,937Filed 11 Jan 2007 · continuation

Priority

EP 0401641413 Jul 2004

Published

US 2010/0255032 A17 Oct 2010

Granted

1 Jan 2013

Term ends

Not estimatedThe source records don’t support an estimate.

Classification12 codes

A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…
A61K 31/70
Medicinal preparations containing organic active ingredients: carbohydrates; Sugars; Derivatives thereof
A61K 35/76
Microorganisms or materials therefrom: viruses; Subviral particles; Bacteriophages
A61P 31/18
For RNA viruses: for HIV

Parapoxviruses in combination with other antiviral agents for the treatment of viral diseases

Life of this patent

Parapoxviruses in combination with other antiviral agents for the treatment of viral diseases

Life of this patent

Abstract

Claims14